Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Innohep versus warfarin for acute venous thromboembolism in patients with active cancer
2009-018141-20Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- May 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in venous thromboembolism (VTE) comparing Innohep arm with Warfarin arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started May 2010; status: completed.
02
Drugs
tinzaparinwarfarin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2009-018141-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018141-20.